Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour.
about
Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaBDAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosisAn intronic microRNA silences genes that are functionally antagonistic to its host geneDAB2IP in cancerTherapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancerNegative regulation of DAB2IP by Akt and SCFFbw7 pathwaysA common genetic variant (97906C>A) of DAB2IP/AIP1 is associated with an increased risk and early onset of lung cancer in Chinese males.Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.Differential Regulation of RasGAPs in Cancer.DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach.Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers.A Novel Monoclonal Antibody Against Human DAB2IP.Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancerThe positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer.The mechanism of DAB2IP in chemoresistance of prostate cancer cells.Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high-risk prostate cancer patients with worse survival following radiation therapySmurf1 regulation of DAB2IP controls cell proliferation and migrationA mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer.Inhibition and termination of physiological responses by GTPase activating proteins.Nonredundant functions for Ras GTPase-activating proteins in tissue homeostasis.Breast- and salivary gland-derived adenoid cystic carcinomas: potential post-transcriptional divergencies. A pilot study based on miRNA expression profiling of four cases and review of the potential relevance of the findings.The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1.Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.The role of DAB2IP in androgen receptor activation during prostate cancer progression.Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.Loss of DAB2IP expression in human urothelial carcinoma is associated with poorer recurrence-free survival.The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios.Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.Expression patterns of human DAB2IP protein in fetal tissues.DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway.Disabled homolog 2 interactive protein functions as a tumor suppressor in osteosarcoma cells.Low expression level of ASK1-interacting protein-1 correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer
P2860
Q24295609-C9688A1C-FBA5-445D-948F-0A241FF8E1D5Q24299235-028424A4-3AC2-4431-A8EB-709F4BDBCB57Q24316141-CA6F2F23-D1D0-4AF8-8E61-8BF9E5A8E0D6Q24653379-AC4259E7-A902-4E28-860C-04BDCB687F82Q26776456-4E2162C2-0CF8-4C8D-A374-FF15F3C34CFBQ33863328-E10F933E-318C-4F5A-BC84-13B8B759F664Q33917635-6836D8CB-A518-481A-B16D-ACFD990E38DDQ34064865-3855B72A-CE05-41D8-AC50-A3F97F3E06EFQ35051774-F9030E6C-4584-4B45-A962-80B5F1CAF84AQ35083732-56F609A1-53CF-4BF7-B9BA-2BE6915CF866Q35132907-7A79FC08-3C9C-4F37-B42E-CEBE1A231A4DQ35927921-2E818F39-5046-4218-A612-5EEFFF35DD2DQ36011799-532D9920-D9AB-495D-B0F0-AECBC04155C2Q36275433-EA3420A5-246A-4215-981B-7A44C8EEB900Q36413800-1A68EF4B-AC9C-462D-823E-CD42F8CB4F95Q36725756-49E89478-B541-4077-BBDD-1CD1D9D12BC0Q37084855-2D463A73-9930-49A8-9A47-F2D56902F875Q37295581-4B23B62B-2C77-4CC7-B363-1B352935E712Q37701535-1FB020DF-F9A6-49F8-A6E3-33F3CF738FF4Q37980724-AEA4F1B5-2FED-4647-9747-87C1D5745178Q38084894-D2BE826D-3EE5-43CB-A91A-5D7A2AFF468EQ38252816-2BBA9AAA-E131-469D-A165-21B9C4CFE31AQ38920371-D37C08F2-66E9-479D-B25F-F6351617D7BBQ38973690-1D65E372-5E3D-418E-9FD0-E1DD53E7746AQ39012136-7E9A9B16-D398-401D-8066-9C8E10253F80Q39162930-A766F183-A0F4-42AB-8376-E2D83A3B74E8Q39428754-E0AA0D02-FC73-4710-84DF-400176668ECFQ40839199-2D72F670-4F47-4779-8BE4-2940E820BC6CQ46207048-0C797793-F0F5-4587-BFF1-D74B172FFC5BQ46650545-38DF5B73-7E66-4934-8F2A-5B0C47AA0CCBQ48368680-62D707E2-3E53-4F77-B5B0-2FA4242836CAQ51805745-B1E2FE89-3056-429A-989C-10892CC1202AQ54979427-01E03646-DEBD-4DE8-B96B-6225F9505527Q55352221-70214EB0-2CA9-40BE-BF7F-33BF8BD54EE7Q59125922-29BCA645-F365-4450-AE9A-2B2E605DADA2
P2860
Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Aberrant promoter methylation ...... ne in gastrointestinal tumour.
@en
type
label
Aberrant promoter methylation ...... ne in gastrointestinal tumour.
@en
prefLabel
Aberrant promoter methylation ...... ne in gastrointestinal tumour.
@en
P2093
P2860
P356
P1476
Aberrant promoter methylation ...... ene in gastrointestinal tumour
@en
P2093
A F Gazdar
M Murakami
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602458
P407
P577
2005-03-01T00:00:00Z